Skip to main content

Table 1 Characteristics of the cohort at index date

From: Blood neutrophil counts are associated with exacerbation frequency and mortality in COPD

 

All

Normal index BNC

Elevated

index BNC

Significance

n

7220

4465 (62%)

2462 (34%)

 

Age

75 (65, 81)

72 (64, 80)

74 (67, 82)

P < 0.001

Male Gender

3470 (48%)

2149 (48%)

1171 (48%)

P = 0.67

BMI

28 (24, 31)

28 (24, 31)

28 (23, 32)

P = 0.63

ICS usea

4525 (63%)

2680 (60%)

1635 (66%)

P < 0.001

LABA only

146 (2%)

101 (2%)

42 (2%)

P = 0.14

LAMA only

555 (8%)

339 (8%)

196 (8%)

P = 0.61

LABA & LAMA

168 (2%)

103 (2%)

58 (2%)

P = 0.96

SABA

6068 (84%)

3672 (82%)

2137 (87%)

P < 0.001

Current smokers

3494 (48%)

2104 (47%)

1264 (51%)

P = 0.02

Ex-smokers

3300(46%)

2071 (46%)

1078 (44%)

 

Spirometry

   

P < 0.001

FEV1 (Litres)

1.58 (1.11, 1.98)

1.64 (1.23, 1.91)

1.49 (1.00, 1.87)

 

GOLD 2017

   

P = 0.002

A

332 (8%)

243 (9%)

82 (6%)

 

B

2174 (51%)

1464 (54%)

646 (46%)

 

C

132 (3%)

99 (4%)

30 (2%)

 

D

1620 (38%)

888 (33%)

634 (46%)

 

Index total white cell count (cells/μL)

8300 (6900, 1030)

7300 (6300, 8300)

10,800 (9700, 12,600)

P < 0.001

Index BNC (cells/μL)

5200 (4000, 7000)

4300 (3600, 5100)

7600 (6600, 9400)

P < 0.001

Index eosinophil count (cells/μL)

180 (90, 290)

200 (120, 300)

150 (60, 280)

P < 0.001

< 150

2960 (41%)

1518 (34%)

1206 (49%)

 

> 150; < 300

2521 (35%)

1765 (40%)

720 (30%)

 

> 300; < 500

1253 (17%)

869 (19%)

369 (15%)

 

> 500

486 (7%)

313 (7%)

167 (7%)

 

Exacerbation frequency (year to index date)

   

P < 0.001

0

2679 (37%)

1797 (40%)

792 (32%)

 

1

1653 (23%)

1075 (24%)

535 (22%)

 

2

1033 (14%)

606 (14%)

380 (15%)

 

3 or more

1855 (26%)

987 (22%)

755 (31%)

 

Severe exacerbation (year to index date)

577 (8%)

162 (4%)

334 (14%)

 

Exacerbation frequency (year from index date)

   

P < 0.001

0

2989 (41%)

1870 (42%)

988 (40%)

 

1

1549 (21%)

1019 (23%)

493 (20%)

 

2

1005 (14%)

649 (15%)

329 (13%)

 

3 or more

1677 (23%)

927 (21%)

652 (26%)

 

Severe exacerbation (year from index date)

633 (9%)

245 (5%)

322 (13%)

 

Crude mortality rate

(per 100 person-years)

10.0

7.9

14.0

P < 0.001

  1. Abbreviations: BNC Blood Neutrophil Count, ICS Inhaled corticosteroids, BMI Body mass index, MRC Medical Research Council, FEV1 Forced expiratory volume in 1 s, FVC Forced vital capacity, aincludes medication used in combination with other bronchodilators or inhaled steroids. Each cell contains the median (IQR) or n (%). Not every measurement is available for every individual at the index visit hence not all percentages add up to 100%. T-tests were used to estimate the significance of differences between the characteristics of the groups, except for categorical variables where Chi-squared tests were used and ones where the distributions within either group failed the Shapiro-Wilks test of normality and the Mann-Whitney test was used instead. The large sample size made some small differences statistically significant.